Carey RM, Moran AE, Whelton PK. Treatment of hypertension: a review. JAMA. 2022;328:1849–61.

Article  CAS  PubMed  Google Scholar 

Van Gelder IC, Rienstra M, Crijns HJ, Olshansky B. Rate control in atrial fibrillation. Lancet. 2016;388:818–28.

Article  PubMed  Google Scholar 

Sorbets E, Steg PG, Young R, Danchin N, Greenlaw N, Ford I, et al. β-blockers, calcium antagonists, and mortality in stable coronary artery disease: an international cohort study. Eur Heart J. 2019;40:1399–407.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rodriguez-Gabella T, Catalá P, Muñoz-García AJ, Nombela-Franco L, Del Valle R, Gutiérrez E, et al. Renin-angiotensin system inhibition following transcatheter aortic valve replacement. J Am Coll Cardiol. 2019;74:631–41.

Article  CAS  PubMed  Google Scholar 

Saito T, Yoshijima N, Hase H, Yashima F, Tsuruta H, Simizu H, et al. Impact of beta blockers on patients undergoing transcatheter aortic valve replacement: the OCEAN-TAVI registry. Open Heart. 2020. https://doi.org/10.1136/openhrt-2020-001269.

Article  PubMed  PubMed Central  Google Scholar 

Imamura T, Narang N, Onoda H, Tanaka S, Ushijima R, Sobajima M, et al. Negative prognostic impact of mineralocorticoid receptor antagonist in elderly patients receiving TAVR. J Clin Med. 2023. https://doi.org/10.3390/jcm12113742.

Article  PubMed  PubMed Central  Google Scholar 

Packer M, O’Connor CM, Ghali JK, Pressler ML, Carson PE, Belkin RN, et al. Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective randomized amlodipine survival evaluation study group. N Engl J Med. 1996. https://doi.org/10.1056/NEJM199610103351504.

Article  PubMed  Google Scholar 

Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, et al. 2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the american college of cardiology/american heart association joint committee on clinical practice guidelines. Circulation. 2022;145:e895–1032.

PubMed  Google Scholar 

McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42:3599–726.

Article  CAS  PubMed  Google Scholar 

Tsutsui H, Isobe M, Ito H, Ito H, Lkumura K, Ono M, et al. JCS 2017/JHFS 2017 guideline on diagnosis and treatment of acute and chronic heart failure-digest version. Circ J. 2019;83:2084–184.

Article  PubMed  Google Scholar 

Saeed S, Mancia G, Rajani R, Parkin D, Chambers JB. Antihypertensive treatment with calcium channel blockers in patients with moderate or severe aortic stenosis: Relationship with all-cause mortality. Int J Cardiol. 2020;298:122–5.

Article  PubMed  Google Scholar 

Mitchell C, Rahko PS, Blauwet LA, Canaday B, Finstuen JA, Foster MC, et al. Guidelines for performing a comprehensive transthoracic echocardiographic examination in adults: recommendations from the american society of echocardiography. J Am Soc Echocardiogr. 2019;32:1–64.

Article  PubMed  Google Scholar 

Ouwerkerk W, Voors AA, Zwinderman AH. Factors influencing the predictive power of models for predicting mortality and/or heart failure hospitalization in patients with heart failure. JACC Heart Fail. 2014;2:429–36.

Article  PubMed  Google Scholar 

Patel K, Fonarow GC, Ahmed M, Morgan C, Kilgore M, Love TE, et al. Calcium channel blockers and outcomes in older patients with heart failure and preserved ejection fraction. Circ Heart Fail. 2014;7:945–52.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Matsumoto S, Kondo T, Yang M, Campbell RT, Docherty KF, Boer RA, et al. Calcium channel blocker use and outcomes in patients with heart failure and mildly reduced and preserved ejection fraction. Eur J Heart Fail. 2023;25:2202–14.

Article  CAS  PubMed  Google Scholar 

Mancia G, Kreutz R, Brunström M, Burnier M, Grassi G, Januszewicz A, et al. 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European society of hypertension: endorsed by the international society of hypertension (ISH) and the european renal association (ERA). J Hypertens. 2023;41:1874–2071.

Article  CAS  PubMed  Google Scholar 

Reboussin DM, Allen NB, Griswold ME, Guallar E, Hong Y, Lackland DT, et al. Systematic Review for the 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American college of cardiology/american heart association task force on clinical practice guidelines. Hypertension. 2018;71:e116–35.

Article  CAS  PubMed  Google Scholar 

Gotzmann M, Lindstaedt M, Bojara W, Mügge A, Germing A. Hemodynamic results and changes in myocardial function after transcatheter aortic valve implantation. Am Heart J. 2010;159:926–32.

Article  PubMed  Google Scholar 

Perlman GY, Loncar S, Pollak A, Gilon D, Alcalai R, Planer D, et al. Post-procedural hypertension following transcatheter aortic valve implantation: incidence and clinical significance. JACC Cardiovasc Interv. 2013;6:472–8.

Article  PubMed  Google Scholar 

Lindman BR, Otto CM, Douglas PS, Hahn RT, Elmariah S, Weissman NJ, et al. Blood pressure and arterial load after transcatheter aortic valve replacement for aortic stenosis. Circ Cardiovasc Imag. 2017. https://doi.org/10.1161/CIRCIMAGING.116.006308.

Article  Google Scholar 

Lindman BR, Goel K, Bermejo J, Beckman J, O’Leary J, Barker CM, et al. Lower blood pressure after transcatheter or surgical aortic valve replacement is associated with increased mortality. J Am Heart Assoc. 2019;8: e014020.

Article  PubMed  PubMed Central  Google Scholar 

Klinkhammer BJ, Dyke CM, Haldis TA. The development or worsening of hypertension after transcatheter aortic valve replacement (TAVR) improves short-term and long-term patient outcomes. Heart Asia. 2018;10: e010994.

Article  PubMed  PubMed Central  Google Scholar 

Kapoor JR, Kapoor R, Ju C, Heidenreich PA, Eapen ZJ, Hernandez AF, et al. Precipitating clinical factors, heart failure characterization, and outcomes in patients hospitalized with heart failure with reduced, borderline, and preserved ejection fraction. JACC Heart Fail. 2016;4:464–72.

Article  PubMed  Google Scholar 

Mitchell GF, Vasan RS, Keyes MJ, Parise H, Wang TJ, Larson MG, et al. Pulse pressure and risk of new-onset atrial fibrillation. JAMA. 2007;297:709–15.

Article  CAS  PubMed  Google Scholar 

Stewart BF, Siscovick D, Lind BK, Gardin M, Gottdiener JS, Smith VE, et al. Clinical factors associated with calcific aortic valve disease. Cardiovascular health study. J Am Coll Cardiol. 1997. https://doi.org/10.1016/S0735-1097(96)00563-3.

Article  PubMed  Google Scholar 

Iung B. Interface between valve disease and ischaemic heart disease. Heart. 2000;84:347–52.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nissen SE, Tuzcu EM, Libby P, Thompson PD, Ghali M, Garza D, et al. Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial. JAMA. 2004;292:2217–25.

Article  CAS  PubMed  Google Scholar